Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -€32.29 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are €88.18 Million. In 2020 the company made an earning of -€38.59 Million, an increase over its 2019 earnings that were of -€79.29 Million.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year	Earnings	Change
2021 (TTM)	-€32.29 Million	-16.32%
2020	-€38.59 Million	-51.34%
2019	-€79.29 Million	-19.45%
2018	-€98.44 Million	28.96%
2017	-€76.34 Million	42.3%
2016	-€53.65 Million	6.18%
2015	-€50.53 Million	-410.24%
2014	€16.28 M	-67.53%
2013	€50.15 M

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Zogenix ZGNX	-€0.19 Billion	448.89%	🇺🇸 USA
Supernus Pharmaceuticals SUPN	€86.08 M	-353.36%	🇺🇸 USA
AbbVie ABBV	€3.26 B	-9,719.72%	🇺🇸 USA
GlaxoSmithKline GSK	€3.86 B	-11,476.27%	🇬🇧 UK
Merck MRK	€18.65 B	-54,999.17%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -€32.29 Million